Icotinib Is as Efficacious as Gefitinib for Brain Metastasis of EGFR Mutated Non-Small-Cell Lung Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6543-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Trial-Based Cost-Utility Analysis of Icotinib Versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China

PLoS ONE
Multidisciplinary
2016English

Gefitinib Radiosensitizes Non-Small Cell Lung Cancer Cells Through Inhibition of Ataxia Telangiectasia Mutated

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

P3.01-92 Blood Test Parameters as Prognostic Factors in EGFR-Mutated Non-Small Cell Lung Cancer Treated With TKIs

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Patient-Reported Outcomes From FLAURA: Osimertinib Versus Erlotinib or Gefitinib in Patients With EGFR-mutated Advanced Non-Small-Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2020English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Enhanced Efficacy of AZD3759 and Radiation on Brain Metastasis From EGFR Mutant Non-Small Cell Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

P113 Icotinib Alone or With Radio Therapy Inpatients With EGFR Mutations Non-Small Cell Lung Cancer Who Develop Brain Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer

PLoS ONE
Multidisciplinary
2009English

Neurocognitive Function and Quality of Life in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases Treated With Icotinib and Whole-Brain Radiation: Results of a Phase 1 Trial

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy